XOMA Royalty Corporation - Common Stock —— 股息历史与收益率 (NASDAQ:XOMA) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计股息

每季度年度

每股股息 —————— — 股息收益率 % —————— — 派息率 % —————— —

新闻

Goldman Sachs Hits Record High, Leads 15 Newcomers To Best Growth Stock Lists

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates

CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates

XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last?

Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal

Exclusive | Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million

Turbine Season for Tech: John Rowland on the Next Era of AI Data Center Investments

XOMA Royalty Corporation (XOMA) Q4 2025 Earnings Call Transcript

XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - XOMA Royalty (NASDAQ:XOMA)